Translational Research and Plasma Proteomic in Cancer.

作者: Annamaria Chiara Santini , Giancarlo Giovane , Adelaide Auletta , Angelina Di Carlo , Alfonso Fiorelli

DOI: 10.1002/JCB.25413

关键词:

摘要: Proteomics is a recent field of research in molecular biology that can help the fight against cancer through search for biomarkers detect this disease early stages its development. Proteomic speedily growing technology, also thanks to development even more sensitive and fast mass spectrometry analysis. Although technique most widespread discovery new biomarkers, it still suffers poor sensitivity insufficient reproducibility, essentially due tumor heterogeneity. Common technical shortcomings include limitations detecting low abundant possible systematic biases observed data. Current attempts are trying develop high-resolution proteomic instrumentation high-throughput monitoring protein changes occur cancer. In review, we describe basic features tools which have proven be useful research, showing their advantages disadvantages. The application these could provide detection various types improve understanding mechanisms growth dissemination.

参考文章(70)
Hongbing Shi, Haifeng Deng, Jingting Jiang, Kexin Zhang, Mingyang Lu, Chong Li, Bin Xu, Lujun Chen, Zhigang Wang, Juan Liu, Yongyi Zou, Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression. International Journal of Clinical and Experimental Pathology. ,vol. 8, pp. 629- 635 ,(2015)
Natalie J. Serkova, Kristine Glunde, Metabolomics of cancer. Methods of Molecular Biology. ,vol. 520, pp. 273- 295 ,(2009) , 10.1007/978-1-60327-811-9_20
Donglin Liu, Chien-Hsing Chang, David V. Gold, David M. Goldenberg, Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer. Oncotarget. ,vol. 6, pp. 4274- 4285 ,(2015) , 10.18632/ONCOTARGET.2760
Jie Yang, Fan Yang, Jiqin Nie, Xiaohua Zou, Huiqun Tian, Yu'e Qin, Chaoqi Liu, None, Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer. Cancer Biomarkers. ,vol. 15, pp. 205- 211 ,(2015) , 10.3233/CBM-140455
N. Leigh Anderson, Malu Polanski, A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights. ,vol. 1, pp. 1- 48 ,(2006) , 10.4137/BMI.S0
Zheqi Li, Zhenghua Wu, Hao Chen, Qi Zhu, Guangwei Gao, Lingyun Hu, Hema Negi, Suchitra Kamle, Dawei Li, Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration. Medical Oncology. ,vol. 32, pp. 178- ,(2015) , 10.1007/S12032-015-0577-Z
Timothy M Pawlik, David H Hawke, Yanna Liu, Savitri Krishnamurthy, Herbert Fritsche, Kelly K Hunt, Henry M Kuerer, Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein BMC Cancer. ,vol. 6, pp. 68- 68 ,(2006) , 10.1186/1471-2407-6-68
Dingmiao Wang, Ting Hao, Yang Pan, Xiaowei Qian, Daixing Zhou, Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer Molecular and Cellular Biochemistry. ,vol. 402, pp. 75- 82 ,(2015) , 10.1007/S11010-014-2315-9
XUEBING YAN, LEILEI YAN, SIHONG LIU, ZEZHI SHAN, YUAN TIAN, ZHIMING JIN, N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer. Molecular Medicine Reports. ,vol. 12, pp. 2999- 3006 ,(2015) , 10.3892/MMR.2015.3687